Page last updated: 2024-10-21

2,2'-azobis(2-amidinopropane) and Chronic Disease

2,2'-azobis(2-amidinopropane) has been researched along with Chronic Disease in 2 studies

2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiu, HF1
Cheng, JK1
Lin, PH1
Chang, JC1
Chen, IM1
Lin, CI1
Chang, WP1
Lin, CH1
Nishioka, T1
Yamamoto, Y2

Other Studies

2 other studies available for 2,2'-azobis(2-amidinopropane) and Chronic Disease

ArticleYear
A mechanistic study on urine retention in d-amphetamine addicts.
    The Chinese journal of physiology, 2014, Aug-31, Volume: 57, Issue:4

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Afferent Pathways; Amidines; Amphetamine-Related Disorders; An

2014
[Studies on the influence of long-term doses of lipid peroxide generators on rat pancreas].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1992, Volume: 89, Issue:9

    Topics: Amidines; Animals; Chronic Disease; Free Radical Scavengers; Free Radicals; Glutathione Peroxidase;

1992